Literature DB >> 17948085

The "1st septal unit" in hypertrophic obstructive cardiomyopathy: a newly recognized anatomo-functional entity, identified during recent alcohol septal ablation experience.

Paolo Angelini1.   

Abstract

In hypertrophic obstructive cardiomyopathy, selective and asymmetric hypertrophy results in a stenotic subaortic channel, which is further narrowed by a Venturi effect (suctioning of the anterior leaflet, manifested by systolic anterior motion of the mitral valve). Better understanding of these essential pathophysiologic mechanisms has led to the definition of a new anatomo-functional entity, the 1st septal unit, which consists of the basal interventricular septal hypertrophy and its related septal arterial branches. As an alternative to surgical myomectomy, alcohol septal ablation is an effective method of reducing subaortic stenosis and improving mitral valve function. After alcohol ablation, global negative remodeling of the hypertrophied left ventricle eventually ensues. This review presents specific anatomic and functional features of a newly identified pathophysiologic entity (the 1st septal unit) in relation to the clinical manifestations and natural history of hypertrophic obstructive cardiomyopathy. This relationship is also relevant during the performance of alcohol septal ablation interventions: related operative suggestions are provided for optimizing subaortic stenosis relief during septal ablation and for preventing complications.

Entities:  

Keywords:  Alcohol septal ablation; asymmetric septal hypertrophy; cardiomyopathy, hypertrophic obstructive/physiopathology/therapy; coronary vessels/anatomy; ethanol/therapeutic use; first septal unit; heart septum

Mesh:

Substances:

Year:  2007        PMID: 17948085      PMCID: PMC1995043     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  60 in total

Review 1.  New concepts in hypertrophic cardiomyopathies, part I.

Authors:  R Roberts; U Sigwart
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

2.  MRI Versus 3D echocardiography in postinterventional patients with hypertrophic obstructive cardiomyopathy.

Authors:  A Franke; H P Kühl; F A Schoendube
Journal:  Circulation       Date:  2001-08-14       Impact factor: 29.690

3.  The anatomy of the septal perforating arteries in normal and congenitally malformed hearts.

Authors:  A R Hosseinpour; R H Anderson; S Y Ho
Journal:  J Thorac Cardiovasc Surg       Date:  2001-06       Impact factor: 5.209

4.  MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.

Authors:  Yasuo Amano; Morimasa Takayama; Maki Amano; Tatsuo Kumazaki
Journal:  AJR Am J Roentgenol       Date:  2004-02       Impact factor: 3.959

5.  Blood supply of the human interventricular septum in north-west Indians.

Authors:  D Sahni; I Jit
Journal:  Indian Heart J       Date:  1990 May-Jun

6.  Transcoronary chemical ablation of ventricular tachycardia.

Authors:  P Brugada; H de Swart; J L Smeets; H J Wellens
Journal:  Circulation       Date:  1989-03       Impact factor: 29.690

7.  The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy. Experience over 15 years.

Authors:  R Mohr; H V Schaff; G K Danielson; F J Puga; J R Pluth; A J Tajik
Journal:  J Thorac Cardiovasc Surg       Date:  1989-05       Impact factor: 5.209

8.  Morphological determinants of echocardiographic patterns of mitral valve systolic anterior motion in obstructive hypertrophic cardiomyopathy.

Authors:  H G Klues; W C Roberts; B J Maron
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

9.  Surgical correction of hypertrophic obstructive cardiomyopathy with combined myectomy, mobilisation and partial excision of the papillary muscles.

Authors:  F A Schoendube; H G Klues; S Reith; B J Messmer
Journal:  Eur J Cardiothorac Surg       Date:  1994       Impact factor: 4.191

10.  Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy.

Authors:  L H Cohn; H Trehan; J J Collins
Journal:  Am J Cardiol       Date:  1992-09-01       Impact factor: 2.778

View more
  9 in total

1.  A TASH experience: post-infarction myocardial oedema necessitating the support of ECMO and occurrence of significant mitral regurgitation.

Authors:  D Basic; H Möllmann; M A Haas; A Rolf; A Jovanovic; Christoph Liebetrau; Sebastian Szardien; J Leick; Oliver Dörr; A Skwara; T Walther; C W Hamm; H M Nef
Journal:  Clin Res Cardiol       Date:  2011-12-27       Impact factor: 5.460

Review 2.  Transcatheter septal ablation in hypertrophic obstructive cardiomyopathy: a technical guide and review of published results.

Authors:  Angelos G Rigopoulos; Stefanos Sakellaropoulos; Muhammad Ali; Sophie Mavrogeni; Athanassios Manginas; Matthias Pauschinger; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

3.  Serial septal branch assessment in hypertrophic obstructive cardiomyopathy: New echocardiographic contrast agent for alcohol septal ablation.

Authors:  A G Rigopoulos; B Pfeiffer; H Seggewiss
Journal:  Herz       Date:  2013-04-17       Impact factor: 1.443

4.  Septal myectomy after failed septal alcohol ablation.

Authors:  Eduard Quintana; Pietro Bajona; María José Arguis; Susanna Prat-González
Journal:  Ann Cardiothorac Surg       Date:  2017-07

5.  Apical hypertrophic cardiomyopathy: preliminary attempt at palliation with use of subselective alcohol ablation.

Authors:  Paolo Angelini; Carlo Uribe; Jorge Monge; Jorge M Escobar; Eduardo Hernandez-Vila
Journal:  Tex Heart Inst J       Date:  2012

6.  Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alcohol (1 ml) is still effective.

Authors:  Josef Veselka; David Zemánek; Pavol Tomasov; Radka Duchonová; Katerina Linhartová
Journal:  Heart Vessels       Date:  2009-01-23       Impact factor: 2.037

Review 7.  Glue septal ablation: A promising alternative to alcohol septal ablation.

Authors:  Sercan Okutucu; Kudret Aytemir; Ali Oto
Journal:  JRSM Cardiovasc Dis       Date:  2016-03-03

Review 8.  Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy.

Authors:  Angelos G Rigopoulos; Hubert Seggewiss
Journal:  Curr Cardiol Rev       Date:  2016

9.  Alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

Authors:  Hicham El Masry; Jeffrey A Breall
Journal:  Curr Cardiol Rev       Date:  2008-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.